BCDA
BioCardia, Inc.
1.22
1 x 0.88
2 x 1.53
bid
ask
+
0.03
2.10%
09:56 AM
timesize
| Ytd | -2.80% | |
| 1y | -41.59% |
1.19
day range
1.24
0.80
52 week range
2.42
| Open | 1.19 | Prev Close | 1.19 | Low | 1.19 | High | 1.24 | Mkt Cap | 18.08M |
| Vol | 83.88K | Avg Vol | 3.09M | EPS | -0.85 | P/E | N/A | Forward P/E | -1.57 |
| Beta | 1.27 | Short Ratio | 1.41 | Inst. Own | 2.21% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 1.02 | 200-d Avg | 1.24 | 1yr Est | 25.00 |
| Income Statement | |||
| Operating Expenses | 2.27M | ||
| Research and Development Expense | 1.24M | ||
| Selling, General and Administrative Expense | 1.03M | ||
| Operating Income | -2.27M | ||
| Net Income | -2.26M | ||
| Net Income Common Stock | -2.26M | ||
| Net Income Common Stock (USD) | -2.26M | ||
| Consolidated Income | -2.26M | ||
| Earnings per Basic Share | -0.21 | ||
| Earnings per Basic Share (USD) | -0.21 | ||
| Earnings per Diluted Share | -0.21 | ||
| Earning Before Interest & Taxes (EBIT) | -2.26M | ||
| Earning Before Interest & Taxes (USD) | -2.26M | ||
| Weighted Average Shares | 10.81M | ||
| Weighted Average Shares Diluted | 10.81M | ||
| Balance Sheet | |||
| Cash and Equivalents | 951.00K | ||
| Cash and Equivalents (USD) | 951.00K | ||
| Trade and Non-Trade Receivables | 20.00K | ||
| Current Assets | 1.14M | ||
| Property, Plant & Equipment Net | 401.00K | ||
| Total Assets | 1.71M | ||
| Debt Current | 412.00K | ||
| Total Debt | 412.00K | ||
| Current Liabilities | 2.78M | ||
| Total Liabilities | 2.78M | ||
| Accumulated Retained Earnings (Deficit) | -170.61M | ||
| Shareholders Equity | -1.07M | ||
| Shareholders Equity (USD) | -1.07M | ||
| Assets Non-Current | 572.00K | ||
| Total Debt (USD) | 412.00K | ||
| Trade and Non-Trade Payables | 820.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 124.00K | ||
| Net Cash Flow from Financing | 117.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.54M | ||
| Capital Expenditure | -3.00K | ||
| Issuance (Purchase) of Equity Shares | 225.00K | ||
| Net Cash Flow from Investing | -3.00K | ||
| Net Cash Flow from Operations | -1.66M | ||
| Share Based Compensation | 113.00K | ||